𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Methotrexate and sulfasalazine combination therapy: Is it worth the risk?

✍ Scribed by Sarah L. Morgan; Joseph E. Baggott; Graciela S. Alarcón

Book ID
112002550
Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
164 KB
Volume
36
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Is it worth the risk?
Is it worth the risk?
✍ Jesus Apuya 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 48 KB
Sulfasalazine is a potent inhibitor of t
Sulfasalazine is a potent inhibitor of the reduced folate carrier: Implications for combination therapies with methotrexate in rheumatoid arthritis
✍ Gerrit Jansen; Joost van der Heijden; Ruud Oerlemans; Willem F. Lems; Ilan Iferg 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB 👁 2 views

## Abstract ## Objective To investigate whether interactions of sulfasalazine (SSZ) with reduced folate carrier (RFC), the dominant cell membrane transporter for natural folates and methotrexate (MTX), may limit the efficacy of combination therapy with MTX and SSZ in patients with rheumatoid arthr